Oxybuprocaine
| 220px | |
| Oxybuprocaine
| |
| Systematic (IUPAC) name | |
| 2-diethylaminoethyl 4-amino-3-butoxy-benzoate | |
| Identifiers | |
| CAS number | |
| ATC code | D04 S01HA02 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H29ClN2O3 |
| Mol. mass | 344.877 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Oxybuprocaine | |
|
Articles | |
|---|---|
|
Most recent articles on Oxybuprocaine Most cited articles on Oxybuprocaine | |
|
Media | |
|
Powerpoint slides on Oxybuprocaine | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Oxybuprocaine at Clinical Trials.gov Trial results on Oxybuprocaine Clinical Trials on Oxybuprocaine at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Oxybuprocaine NICE Guidance on Oxybuprocaine
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Oxybuprocaine Discussion groups on Oxybuprocaine Patient Handouts on Oxybuprocaine Directions to Hospitals Treating Oxybuprocaine Risk calculators and risk factors for Oxybuprocaine
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Oxybuprocaine | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Overview
Oxybuprocaine is the name of a local anesthetic, which is used especially in ophthalmology and otolaryngology. Oxybuprocaine is sold by Novartis under the brand names Novesine or Novesin.
Where oxybuprocaine is used specifically
- In ophthalmology in order to numb the surface of the eye (the outermost layers of the cornea and conjunctiva) for the following purposes:
- In order to perform a contact/applanation tonometry.
- In order to remove small foreign objects from the uppermost layer of the cornea or conjunctiva.
- In otolaryngology for numbing the mucous membranes of the nostrils.
Topical anesthetics in general
Oxybuprocaine like any other topical anesthetic used in the eye (like for example tetracaine, proxymetacaine and proparacaine) can cause irreversible corneal damage and even complete destruction of the cornea when used excessively (excessive use means several times a day during several days or even weeks).
See also
Antipruritics (D04) | |
|---|---|
| Antihistamines for topical use | Thonzylamine - Mepyramine - Thenalidine - Tripelennamine - Chloropyramine - Promethazine - Tolpropamine - Dimetindene - Clemastine - Bamipine - Isothipendyl - Diphenhydramine - Chlorphenoxamine |
| Anesthetics for topical use | Lidocaine - Cinchocaine - Oxybuprocaine - Benzocaine - Quinisocaine - Tetracaine - Pramocaine |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies